HomeConditionsParoxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare blood disorder causing anemia, blood clots, and bone marrow dysfunction. Symptoms vary but may include fatigue, dark urine, abdominal pain, and increased clotting. Diagnosis involves specialized tests like flow cytometry. Treatment options include blood transfusions, medications, anticoagulants, and bone marrow transplants. The outlook for PNH patients has improved, and proper management can significantly enhance quality of life.

Best medications for Paroxysmal Nocturnal Hemoglobinuria

Drug NameClassRouteStandard DosagePrice
EmpaveliC3 InhibitorsSubcutaneous1080 MG/20MLfrom$4734.02

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and potentially life-threatening blood disorder characterized by the destruction of red blood cells (hemolytic anemia), blood clots (thrombosis), and impaired bone marrow function. This condition is caused by a mutation in the PIG-A gene, which leads to a deficiency of certain proteins on the surface of blood cells. PNH can affect individuals of any age, although it is most commonly diagnosed in young adulthood.


The symptoms of PNH can vary widely from person to person. Some individuals may only experience mild symptoms, while others may have more severe manifestations. Common symptoms include: 1. Hemolytic anemia: The destruction of red blood cells can lead to fatigue, weakness, and shortness of breath. 2. Dark urine: This occurs due to the presence of hemoglobin released from the damaged red blood cells. 3. Abdominal pain: Blood clots may form in the abdomen, causing pain and swelling. 4. Blood clots: PNH increases the risk of developing blood clots, which can occur in various parts of the body, including the veins (venous thrombosis) and arteries (arterial thrombosis). 5. Bone marrow failure: PNH may also lead to bone marrow failure, resulting in a decrease in the production of other types of blood cells, such as white blood cells and platelets.


Diagnosing PNH involves a combination of medical history evaluation, physical examination, and specialized laboratory tests. A flow cytometry test is usually performed to detect the absence or deficiency of specific proteins on the surface of blood cells. Additionally, other tests such as a complete blood count (CBC), bone marrow biopsy, and genetic testing may be conducted to confirm the diagnosis and assess the extent of the condition.


The main goal of PNH treatment is to manage symptoms, prevent complications, and improve overall quality of life. Treatment options may include: 1. Blood transfusions: These help to alleviate the symptoms of anemia by replacing the damaged red blood cells with healthy ones. 2. Medications: Certain medications, such as eculizumab, can target the underlying cause of PNH by preventing the destruction of red blood cells. 3. Anticoagulants: To reduce the risk of blood clots, anticoagulant medications may be prescribed. 4. Bone marrow transplant: In severe cases, a bone marrow transplant may be considered as a potential curative treatment option.


With advancements in medical treatment, the outlook for individuals with PNH has significantly improved in recent years. Proper management, including regular monitoring and appropriate interventions, can help individuals lead fulfilling lives. It is important for patients to work closely with their healthcare team to develop an individualized treatment plan based on their specific needs and circumstances.